Related Experiment Videos
Bladder carcinoma. Long-term survival and late recurrence
Scandinavian Journal of Urology and Nephrology
|January 1, 1983
Summary
Late recurrence of bladder carcinoma occurs in 34% of patients within 5-10 years post-diagnosis. Large tumor size and high grade are linked to poorer prognosis, emphasizing the need for long-term patient follow-up.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Bladder carcinoma requires understanding long-term outcomes beyond initial treatment.
- Late recurrence and mortality causes in bladder cancer patients are critical areas for research.
Purpose of the Study:
- To analyze the incidence and impact of late recurrence in bladder carcinoma patients.
- To identify prognostic factors associated with long-term survival and recurrence.
Main Methods:
- Retrospective analysis of 115 bladder carcinoma patients with ≥5 years post-diagnosis survival.
- Histologic specimen reclassification according to the Union for International Cancer Control (UICC) criteria.
- Evaluation of recurrence rates, causes of death, and associations with tumor characteristics.
Main Results:
- Late recurrence (5-10 years) was observed in 34% of patients.
- Tumor size and high grade were significantly associated with poorer long-term prognosis.
- 12% died of bladder carcinoma, often due to tumor stage progression; 18% died from intercurrent diseases.
Conclusions:
- Close, long-term follow-up is crucial for bladder carcinoma patients.
- Early detection and treatment of recurrent tumors can improve outcomes.
- Prognostic factors like tumor size and grade inform long-term management strategies.